Balyasny Asset Management
AARD

Balyasny Asset Management’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Balyasny Asset Management’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,435
Closed -$266K – 2594
2025
Q1 		$266K Buy
+35,435
New +$266K ﹤0.01% 1743